Lumpectomy is the gold standard for breast cancer surgery, says Kirstyn E. Brownson, MD, a surgical breast oncologist at Huntsman Cancer Institute. We asked Dr. Brownson to explain what a lumpectomy ...

Each year more than 200,000 women diagnosed with early-stage breast cancer, the most common kind, must make myriad treatment decisions. Among them: whether to have a mastectomy or breast-conserving ...

Many women with two or three breast tumors can get by with lumpectomy surgery instead of having their whole breast removed, a new study suggests. In recent years, more patients with multiple tumors ...

After Katie Couric was diagnosed with breast cancer this summer, one of the first questions swirling in her head was whether she would need a mastectomy — or surgery to remove the entire breast. But ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR ...

Thanks to modern, multimodal breast cancer therapies, 5-year local recurrence rates following lumpectomy have dropped significantly, making breast-conserving surgery (BCS) an option for more patients ...

The same technology used in submarines to detect objects on the ocean floor is being used in the fight against breast cancer. Sonar is helping cancer surgeons remove abnormal tissue within 1 ...

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...